Low molecular weight heparin therapy
Assessment of pregnancy outcome with low molecular weight heparin therapy: a retrospective, single centre observational study
... We retrospectively evaluated the medical records of all the patients who received therapeutic LMWH doses during pregnancy for the various indications over period of 2 years from October 2015 to November 2017 was ...
6
Impact of Pharmaceutical Care on Self Administration of Outpatient Low Molecular Weight Heparin Therapy
... Outpatient subcutaneous (s.c.) therapies are becoming more and more common in the treatment of different diseases. The effectiveness of community-pharmacy-based interventions in preventing problems that arise during s.c. ...
14
The potential benefits of low-molecular-weight heparins in cancer patients
... and Low Molecular Weight-Heparin Therapy (MALT) trial, can- cer patients were randomly assigned to 6-weeks of either the LMWH nadroparin (n = 148) or placebo (n = ...
12
Literature Review on Prophylaxis of Deep Venous Thrombosis and Pulmonary Embolism
... with heparin or fractionated heparin ...particular low molecular weight ...where, heparin cannot be used due to bleeding or thrombocytopenia risk or other contraindications, ...
6
Cancer-associated thrombosis: the when, how and why
... With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism) trial, 406 CAT patients were randomised to receive rivaroxaban 15 mg twice daily for 3 weeks followed by ...
11
Effect of dalteparin, a low-molecular-weight heparin, as adjunctive therapy in patients with Kawasaki disease: a retrospective study
... IVIG therapy in both groups was obtained using the Mantel-Haenstzel method, while the adjusted odds ratio for acute-phase CAL, cardiac se- quelae, and additional IVIG therapy was not analyzed because the ...
7
Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
... of heparin therapy because of its association with arterial and venous thrombosis ...to heparin [2]. The now widespread use of low-molecular-weight heparins for a variety of ...
5
Cancer-associated thrombosis, low-molecular- weight heparin, and the patient experience: a qualitative study
... In conclusion, this study adds further information to what is already known about VTE in the palliative care setting. First, it suggests that CAT produces a significant symptomatic and psychological burden. One could ...
9
Original Article Efficacy and safety of low molecular weight heparin treatment, intermittent pneumatic compression therapy passive ankle exercise and nursing care in preventing deep venous thrombosis of the lower extremity following varicose vein surgery
... anticoagulation therapy using heparin followed by oral anticoagulation agents is cur- rently the most often used treatment for pre- venting PE and the relapse of DVT, although such treatment cannot prevent ...
9
Evaluation of a Dose Monitoring Method for Prophylactic Anticoagulant Therapy with Low Molecular Weight Heparin
... Of 103 cases of cesarean section (including emergent cesarean section) performed at Juntendo Hospital, Tokyo, Japan between October 2009 and January 2010, 37 cases without a past or family history of DVT or pulmonary ...
6
INCIDENCE OF HEPARIN INDUCED THROMBOCYTOPENIA IN A TERTIARY HOSPITAL
... to heparin was taken into consideration and the two main groups of patients were clubbed ...received heparin either prophylactically or therapeutically for any reason during the previous admission and ...
11
Low Molecular Weight Heparin in the Treatment of Venous and Arterial Thromboses in the Premature Infant
... sions regarding safety of LMWH in the ICN can be made from our data, it can be pointed out that no patients incurred bleeding events that necessitated a change in treatment plan. One patient did develop a subependymal ...
7
Update on the clinical use of the low-molecular-weight heparin, parnaparin
... of therapy with parnaparin provides a significant improvement in the exer- cise time on treadmill test compared with baseline, but not in patients receiving ...
13
Role of low molecular weight heparin in treatment of acute pancreatitis
... Despite the limitations of animal models, the data suggest that a similar cascade of events occurs once pancreatitis begins independent of the inciting event or initial mechanism. (50) Animal studies have shown that ...
156
Prognostic assessment for patients with cancer and incidental pulmonary embolism
... of Low-molecular-weight heparin versus Oral Anticoagulant Therapy for the prevention of recurrent venous thromboembolism in patients with cancer (clinical trial acronym); CT: Computed ...
10
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
... of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer [CLOT]; Lee et al), extended duration ...
9
Heparin and other anticoagulants in amniotic fluid embolism (AFE): Literature review and concept of the therapy
... of heparin application in amniotic fluid embolism (AFE) so far and to find out why, when and how heparin or other anticoagulants should be used in ...reported. Heparin (unfractionated heparin) ...
6
Synthesis and Biological Activity of Anticoagulant Heparan Sulfate Glycopolymers
... lengths, molecular weight distributions, block architectures, and composition of pendant and end-group functionalities to ensure biocompatibility of the materials that are designed for service in biological ...
219
Assessment of the Adminstration of Low Molecular Weight Heparin for Hemodialysis Anticoagulation in Comparison to Standard Unfractionated Heparin
... LMWH inhibits factor Xa, whereas UFH inhibits both factor Xa and thrombin equally. Therefore, the anticoagulant effects of LMWH are monitored by measuring the ability of plasma from patients who are treated with LMWH to ...
8
Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
... For all surgical studies the relative risk (LMWH versus Standard heparin) for deep vein thrombosis was 0-74 (95% Cl 0-65-0-86), for pulmonary embolism 0-43 (95% Cl 0-26-0-72), and for ma[r] ...
5